TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Avia Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
130,219
|
150,906
|
145,179 |
| Financial expenses |
48,704
|
26,079
|
20,342 |
| Earnings before taxes |
-9,773
|
-6,656
|
12,753 |
| EBITDA |
5,232
|
8,466
|
20,713 |
| Total assets |
505,835
|
334,471
|
336,196 |
| Current assets |
72,667
|
76,245
|
83,488 |
| Current liabilities |
29,672
|
33,284
|
39,874 |
| Equity capital |
102,563
|
59,130
|
45,757 |
| - share capital |
195
|
202
|
200 |
| Employees (average) |
11
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.3%
|
17.7%
|
13.6% |
| Turnover per employee |
11,838
|
18,863
|
20,740 |
| Profit as a percentage of turnover |
-7.5%
|
-4.4%
|
8.8% |
| Return on assets (ROA) |
7.7%
|
5.8%
|
9.8% |
| Current ratio |
244.9%
|
229.1%
|
209.4% |
| Return on equity (ROE) |
-9.5%
|
-11.3%
|
27.9% |
| Change turnover |
-15,696
|
4,980
|
12,714 |
| Change turnover % |
-11%
|
3%
|
10% |
| Chg. No. of employees |
3
|
1
|
1 |
| Chg. No. of employees % |
38%
|
14%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.